Long-Term Longitudinal QoL in Patients Undergoing EEA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04087902

Recruitment Status : Recruiting

First Posted : September 12, 2019

Last Update Posted : October 24, 2023

See Contacts and Locations

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Kyle Wu, Ohio State University

Study Description

Brief Summary:

This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.

Condition or disease
Pituitary Tumor Meningioma Rathke Cleft Cysts Chordoma Chondrosarcoma Craniopharyngioma Encephalocele Esthesioneuroblastoma

Detailed Description:

This is a prospective single-institution longitudinal study to access quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base. Patients will be followed before surgery and up to twenty-four months post-surgery. The primary goal of the study is to assess the alterations to patient quality of life following endoscopic endonasal surgery using modern sinonasal reconstruction techniques. Secondary goals are to better understand the time course of normal healing and patient/procedural risk factors associated with poorer quality of life outcomes.

Study Design

Layout table for study information

Study Type :	Observational
Estimated Enrollment :	400 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	A Prospective Longitudinal Quality of Life Study in Patients Undergoing Endoscopic Endonasal Skull Base Surgery
Actual Study Start Date :	July 16, 2019
Estimated Primary Completion Date :	December 31, 2025
Estimated Study Completion Date :	December 31, 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Genetic and Rare Diseases Information Center resources: Chondrosarcoma Meningioma Olfactory Neuroblastoma Craniopharyngioma Chordoma Encephalocele Ameloblastoma Soft Tissue Sarcoma Neuroblastoma Neuroepithelioma

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

PROMIS-29 quality of life outcome measures for patients undergoing endoscopic endonasal surgeries. [ Time Frame: 24-months post-operatively ]
This study aims to better understand the long-term overall quality of life of patients undergoing endoscopic endonasal surgery using modern sinonasal reconstruction techniques. The PROMIS-29 metric, an overall quality of life metric, will be used to better understand quality of life for patients undergoing this procedure.

Secondary Outcome Measures :

ASK Nasal-12 questionnaire used to measure normal time of healing for patients undergoing endoscopic endonasal surgery [ Time Frame: 24 months post-operatively ]
This study aims to better understand the overall nose function in patients undergoing endoscopic endonasal surgery using modern sinonasal techniques. The ASK Nasal-12 metric is designed to evaluate nose overall nose function such as post-nasal drip, ability to smell, and pain.
Number of patients with long-term quality of life risk factors using PROMIS-29 [ Time Frame: 24 months post-operatively ]
This study aims to better understand the number of long-term risk factors for patients undergoing endoscopic endonasal surgeries using modern sinonasal reconstruction techniques. This will be done using the PROMIS-29 metric along with patient data.
Number of patients with long-term procedural comorbidities using ASK-Nasal 12. [ Time Frame: 24 months post-operatively ]
This study aims to better understand the number of long-term comorbidities for patients undergoing endonasal endoscopic surgeries using modern sinonasal reconstruction techniques. This will be done using the ASK-Nasal 12 metric along with patient data.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:	All
Sampling Method:	Non-Probability Sample

Study Population

Patients who are 18 years of age or older and undergoing surgery via Endoscopic Endonasal Approach.

Criteria

Inclusion Criteria:

Patient is scheduled to undergo endoscopic endonasal surgery. Multiple, staged surgeries are not exclusionary
18 years of age or older
The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent

Exclusion Criteria:

Patient is a prisoner
Patient is not English speaking
Patient is not expected to survive until the 2-year follow-up

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04087902

Contacts

Layout table for location contacts

Contact: Megan Frost, BS	614-685-8622	Megan.Frost@osumc.edu

Locations

Layout table for location information

United States, Ohio
Ohio State University	Recruiting
Columbus, Ohio, United States, 43210
Contact: Megan Frost, BS 614-685-8622 Megan.Frost@osumc.edu
Principal Investigator: Kyle Wu, MD
Sub-Investigator: Daniel Prevedello, MD

Sponsors and Collaborators

Ohio State University

Investigators

Layout table for investigator information

Principal Investigator:	Kyle Wu, MD	Ohio State University

More Information

Layout table for additonal information

Responsible Party:	Kyle Wu, Assistant Professor, Neurological Surgery, Ohio State University
ClinicalTrials.gov Identifier:	NCT04087902
Other Study ID Numbers:	2019H0225
First Posted:	September 12, 2019 Key Record Dates
Last Update Posted:	October 24, 2023
Last Verified:	October 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	No
Plan Description:	There will be no sharing of individual participant data with other researchers. Data will be de-identified once analysis is complete and destroyed once manuscripts are written.

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Keywords provided by Kyle Wu, Ohio State University:


Endoscopic Endonasal Approach Surgery

Additional relevant MeSH terms:

Layout table for MeSH terms

Meningioma Chondrosarcoma Esthesioneuroblastoma, Olfactory Pituitary Neoplasms Craniopharyngioma Adamantinoma Chordoma Central Nervous System Cysts Encephalocele Pituitary Diseases Hypothalamic Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Endocrine System Diseases	Neoplasms, Nerve Tissue Neoplasms by Histologic Type Neoplasms Neoplasms, Vascular Tissue Meningeal Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Sarcoma Neuroblastoma Neuroectodermal Tumors, Primitive, Peripheral Neuroectodermal Tumors, Primitive Neoplasms, Neuroepithelial

To Top